Geriatric Anorexia Study 2.0
Completed
Conditions studied: Healthy, Frailty
In brief
Reduction in appetite and/or food intake among older individuals is referred to as anorexia of aging (AOA, also known as Geriatric Anorexia). AOA is linked with myriad comorbidities associated with aging, contributes significantly to adverse health consequences in old age, and has been used as a predictor of morbidity and mortality. The overall aim of this study is to compare feasibility of body weight, body fat, body composition and activity assessments in elderly subjects in long-term care (LTC), nursing home, or assisted living facilities. This will be accomplished through the use of questionnaires in addition to devices that evaluate movement, body composition, and body weight.
Key facts
- Study ID
- NCT05211973
- Run by
- Boston University
- People needed
- 44
- Starts
- 2022-03-28
- Expected to finish
- 2022-09-07
- Last updated by the study team
- 2022-09-28
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- Treatment with an investigational drug within 30 days of enrollment
- Moderate to severe alcohol use disorder diagnosis within 6 months of the screening as disclosed by the subject
- Participants who are investigational site staff members directly involved in the conduct of the study and their family members, site staff members otherwise supervised by the investigator, or participants who are Boston University/Boston Medical Center (BU/BMC) employees directly involved in the conduct of the study
- Inability to comply with study requirements
- Life expectancy of less than 6 months, or actively enrolled in a palliative care program
- Has any clinically significant medical disorder, condition, disease, or clinically significant finding at screening that precludes subject's participation in study activities
- Participants with electronic implant such as pacemaker etc., due to Bioelectric Impedance Analysis (BIA) body composition devices (Tanita, Smart body scale) using tiny electrical signal for measurements
- At an increased risk of COVID-19 as determined by the Laboratory for Human Neurobiology COVID-19 Human Subject Risk Assessment Survey
- Temperature equal to or above 100.4 degrees F
- Modified Barthel Index of <40
Where it is running
- Evans Biomedical Research Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.